Clinical trial
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
NCT07221799
Study timeline
Study start (estimated)2026-09-01Date precision: day
Registry last updated2025-10-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Neuropathic Painunresolved
Interventions
glibenclamideDRUG · verified · RxNorm: glyburide
PlaceboDRUG
Sponsors & collaborators
University of Maryland, Baltimorelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07221799 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.